Clinical trial on Pregnant Woma

Phase 3

Completed

• Conditions: Health Condition 1: O111- -2146826259Health Condition 2: O140- Mild to moderate pre-eclampsia

• Registration Number: CTRI/2021/04/033099
• Lead Sponsor: Jagdale industries pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Female volunteer aged more than 18 to 45 years

2.If pregnant, should have completed 1st trimester of the pregnancy

3.Pregnant Woman At High Risk For Preeclamsia

4.Willing to give written consent to participate

Exclusion Criteria

1.Patients with preexisting severe systemic disease necessitating long term medication.

2.Patients with known history of diabetes mellitus.

3.Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation.

4.History of cancer including solid tumors hematologic malignancies and carcinoma in situ

5.Any neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.

6.Participation in the current or previous treatment with any approved or investigational health supplements during the past one month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified